Introduction
============

Hearing loss (HL) affects 1--3 of every 1,000 newborns; thus, it is one of the most common sensory disorders in humans ([@b1-ijmm-32-04-0785]). This condition is caused by environmental factors, such as noise or treatment with ototoxic drugs (e.g., aminoglycoside antibiotics) or genomic alterations. Hereditary HL occurs in the presence of defects either in the nuclear genome, as the 35delG mutation in the gene encoding connexin 26 (*GJB2*), or in mitochondrial DNA (mtDNA). Mutations in mtDNA have been shown to be responsible for both maternally inherited syndromic and non-syndromic HL (NSHL) and play a role in the predisposition to aminoglycoside-induced ototoxicity. Jacobs *et al*([@b2-ijmm-32-04-0785]) demonstrated that in Italy, at least 5% of cases of post-lingual, non-syndromic hearing impairment may be attributed to mtDNA mutations. Furthermore, it has been estimated that up to 67% of patients with mtDNA disorders also manifest sensorineural HL (SNHL) ([@b3-ijmm-32-04-0785]). This may be explained by the fact that cells of the cochlea have high oxidative phosphorylation demands, and are thus affected to a greater extent than other cells by a mitochondrial decrease in the protein synthesis rate provoked by mutations in mtDNA.

Non-syndromic SNHL associated with mtDNA mutations is generally progressive ([@b4-ijmm-32-04-0785],[@b5-ijmm-32-04-0785]), involving mainly higher frequencies ([@b6-ijmm-32-04-0785]--[@b8-ijmm-32-04-0785]) and is generally symmetric HL. The onset of HL usually occurs in childhood, is predominantly post-lingual and may be accompanied with vertigo ([@b9-ijmm-32-04-0785]) and tinnitus ([@b10-ijmm-32-04-0785],[@b11-ijmm-32-04-0785]). There is a high variability in severity ranging from normal hearing to profound deafness, even within families presenting similar genotypes ([@b12-ijmm-32-04-0785]--[@b14-ijmm-32-04-0785]); this may be due to the fact that the phenotypic effects are a result of several factors and can develop gradually. Some mtDNA variants, in particular in the *MT*-*RNR1* and *tRNA^Ser(UCN)^* genes, have been identified in several cases as the main cause of SNHL, suggesting that these two loci in particular are hotspots for deafness-associated mutations.

The most commonly reported mutations known to cause HL are A1555G ([@b15-ijmm-32-04-0785]), 961delT ([@b16-ijmm-32-04-0785]--[@b18-ijmm-32-04-0785]), C1494T ([@b19-ijmm-32-04-0785]), A7445G ([@b20-ijmm-32-04-0785],[@b21-ijmm-32-04-0785]), 7472insC ([@b22-ijmm-32-04-0785],[@b23-ijmm-32-04-0785]) and A3243G ([@b24-ijmm-32-04-0785],[@b25-ijmm-32-04-0785]). These variants together with the use of aminoglycosides or in association with other mutations, either mitochondrial or nuclear, can aggravate the condition of hearing impairment.

In particular, it has been documented that, even though the presence of the mutation, A1555G, itself may induce HL ([@b15-ijmm-32-04-0785]), this effect may be worsened in combination with aminoglycoside therapy, as this variant produces a modification in 12 rRNA, making its secondary structure more similar to the corresponding region of *E. coli* 16S rRNA, thus much more vulnerable to the effects of this class of antibiotics ([@b16-ijmm-32-04-0785]).

mtDNA variants, as mutations, deletions or insertions, at position 961 in the same *MT*-*RNR1* gene, have been found in patients with SNHL either with or without a history of aminoglycoside therapy ([@b26-ijmm-32-04-0785],[@b27-ijmm-32-04-0785]). The T\>G substitution in position 961 in particular, has been observed more frequently in hearing-impaired patients compared with controls; thus, it has been suggested to correlate with SNHL ([@b28-ijmm-32-04-0785]).

Taking into consideration that thus far, several mutations have been examined and many are yet to be discovered, in our study, we aimed to identify novel potentially pathogenic mtDNA variants and establish the frequency of the known mutations in our cohort of deaf patients.

Patients and methods
====================

Patients
--------

In collaboration with the Audiology Clinic at the Hospital of Ferrara, Ferrara, Italy we retrieved data on 169 patients suffering from hearing impairment without known aetiology and some of their close relatives. The present study was composed of 102 females and 67 males, with an average age of 20 years (ranging from 0 to 67 years). Their only clinical feature was HL and they did not present any syndromic sign or other clinical abnormalities, including muscular diseases, diabetes, visual dysfunction or neurological disorders. The analysis referred to the audiological tests data. In the audiometric tests, the severity of hearing impairment was defined by pure-tone threshold average (PTA) in frequencies: 500, 1,000, 2,000 and 4,000 Hz. HL of \<20 dB was considered as normal hearing, 21--40 dB mild HL, 41--70 dB moderate HL, 71--90 dB severe HL and \>90 dB profound HL. Written informed consent was provided from all study participants prior to enrollment. Any research involving human subjects was conducted in accordance with the ethical standards of all applicable national and institutional committees and with the World Medical Association's Helsinki Declaration.

Sequence analysis of mtDNA, secondary structure analysis and sequence conservation
----------------------------------------------------------------------------------

Total DNA was extracted from peripheral blood using the Wizard Genomic DNA Purification kit from Promega (Madison, WI, USA). The analysis and search for the mutations in the genes coding for connexin 26 (*GJB2)*, connexin 30 (*GJB6*) and pendrin (*SLC26A4*) were carried out by the Department of Medical Genetics at the Hospital of Ferrara.

From each subject, four regions corresponding to the mitochondrial genomes coding for 12S RNA (*MT*-*RNR1*), tRNA serine 1 (UCN) (*MT-TS1*), tRNA valine (*MT-TV*), tRNA leucine 1 (*MT-TL1*), tRNA aspartic acid (*MT-TD*) and part of 16S rRNA (*MT-RNR2*), NADH dehydrogenase subunit I (*MT-ND1*), cytochrome *c* oxidase subunit I (*MT-CO1*), cytochrome *c* oxidase subunit II (*MT-CO2*) were PCR-amplified. The PCR products were analysed by direct sequencing in the ABI 3730XL or ABI 3100 sequencing machines at BMR Genomics (Padova, Italy). The sequence data were compared to the revised Cambridge Sequence (rCRS), GenBank accession no. NC_012920 (<http://www.ncbi.nlm.nih.gov/nuccore/NC_012920>).

The presence and the nature of all identified nucleotide changes (polymorphisms, putative pathogenic variants, mutations) were confirmed through mitomap (<http://mitomap.org/MITOMAP>) and the Human Mitochondrial Genome Database (<http://www.genpat.uu.se/mtDB/>) which report published and unpublished data on human mtDNA variations and contain a comprehensive database of the complete human mitochondrial genomes, including sequences from GenBank (16,411 sequences with size \>14 kbp) and other sources.

In the subjects harbouring the mutations, A1555G, A3213G, C7792T and T961G, homo/heteroplasmy was determined by electrophoresis on a 1.2% agarose gel following enzymatic digestion as previously described ([@b28-ijmm-32-04-0785]).

The RNAfold software (<http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi>) was used to predict the RNA secondary structure based on minimum energy requirements and base pair probability. The folding of sequences containing novel mutations was compared to the wild-type prediction.

The rCRS and the mitochondrial sequence of 18 different mammals \[*Gorilla gorilla, Cavia porcellus, Capra hircus, Bos Taurus*, *Macaca (fascicularis, sylvanus, mulatta, thibetana), Canis lupus familiaris, Felis catus, Equus asinus, Sus scrofa, Mus musculus, Rattus norvegicus, Pongo abelii, Pongo pygmaeus, Pan paniscus, Pan troglodytes*\] were aligned using the ClustalW2 sequence alignment program (<http://www.ebi.ac.uk/Tools/msa/clustalw2/>) to analyse the conservation of the positions of the new sequence variants identified in our patients. We considered the variants conserved with a conservation rate \>50%.

Results
=======

The 169 subjects presented with idiopathic SNHL and no other symptoms. We performed a mutation analysis of four mtDNA fragments corresponding to the hot spots for HL. We detected mutations in *GJB2* in 43 patients and excluded 18 of them from our analysis as they did not show any association with mtDNA variants.

Comparing the mitochondrial genomes to the rCRS, in our cohort of patients, we found 81 different sequence alterations ([Table I](#tI-ijmm-32-04-0785){ref-type="table"}), including HL-associated A1555G, putatively pathogenic T961G and five other mutations that have never been reported to date. Among the five novel mutations, we hypothesised that one in particular (G786A) may play a role in the onset of aminoglycoside-induced HL.

A1555G
------

Three genetically unrelated subjects harboured the homoplasmic A1555G mutation in the *MT*-*RNR1* gene, a mtDNA variant that has been associated with deafness. The subjects were two females and one male with an average age of 47 years suffering from SNHL. The enzymatic digestion of the fragment showed homoplasmy in all cases. The phenotypes were different as one was congenitally deaf, and the other two had the onset of the symptoms at 5 and at 19 years, respectively; unfortunately, none of them could recall any previous exposure to aminoglycosides ([Table II](#tII-ijmm-32-04-0785){ref-type="table"}).

Audiometric examination in all the affected individuals showed a downsloping curve confirming the typical pattern of mitochondrial SNHL, which implicates the loss of high hearing frequencies ([Fig. 1](#f1-ijmm-32-04-0785){ref-type="fig"}). One of these patients with severe progressive hearing impairment harboured two additional mutations whose pathogenicity has yet to be defined: T3504C, a rare variant in the gene coding for *MT-ND1*; and C7471T, a very rare mtDNA variant located in the extraloop of *tRNA^Ser(UCN)^*.

T961G
-----

Six patients harboured the mutation, T961G, in *MT*-*RNR1*. The phenotypes, as well as the audiometric tests in our T961G cases, were quite disparate as we found two young sisters (mit26 and mit29) with a moderate hearing impairment, whose father and mother were normoacusic even though the latter had the same mtDNA variant. Mit51 showed post-lingual asymmetric progressive HL and in addition to T961G, harboured an additional mutation close to it (C959T) with a low frequency in the databases. Mit116 presented with profound familial congenital SNHL. As for the last two patients, mit178 had hypoplasia of the cochlea and mit186 presented with progressive bilateral HL, which was later diagnosed as partial trisomy of chromosome 6p.

We defined the homoplasmy in all of the cases, with the exception of mit51 whose state could not be determined as the presence of the other mutation in position 959 prevented the *Aci*I restriction enzyme digestion. The comparison of the RNA secondary structure determined by this mutation shows a clear difference with the wild-type one ([Fig. 2](#f2-ijmm-32-04-0785){ref-type="fig"}).

Novel mutations
---------------

We detected novel sequence variants not present in the literature or in mitochondrial databases ([Table III](#tIII-ijmm-32-04-0785){ref-type="table"}), including C712A and the heteroplasmic G786A in *MT*-*RNR1*, A3213G in *MT-RNR2*, C7534T in the D-loop of *TRND* (*tRNAAsp*) and in the *MT-CO2* gene, A7746G, which produces an aminoacidic change in translation. All the mutations were recorded in mitomap (<http://www.mitomap.org/bin/view.pl/MITOMAP/VariantSubmissionList>) and numbered from 20111230001 onwards. In a phylogenetic analysis, we compared the human nucleotide variants with other 18 different mammals and found a conservation rate of \>50% for variants 712, 786 and 3213.

Among the novel mutations, we particularly considered the heteroplasmic G786A in mit7, a 39-year-old female. Her parents and sister were normoacusic and did not harbour any mutations either in mtDNA or in HL-associated genes. She suffered from asymmetric progressive SNHL and had been treated with streptomycin in her childhood. In our alignment analysis, position 786 in the *MT*-*RNR1* gene was quite conserved (14/18); moreover, the mutated secondary structure prediction showed to be different compared to the wild-type one ([Fig. 2](#f2-ijmm-32-04-0785){ref-type="fig"}).

In *MT*-*RNR1* we also found the mutation, C712A, which may have an effect on HL as the site shows a 100% conservation even if no differences in the RNA structure of the gene are detectable. The patient harbouring this variant, a 13-year-old subject with mild SNHL (mit184), harboured two additional mutations of A1811G: a polymorphism and a quite rare C\>A mutation in the evolutionarily conserved position 3546 in the *MT*-*ND1* gene.

A3213G in *MT-RNR2* was detected in a young girl from Morocco harbouring several other variants (A3348G, G3591A, A3714G, G7642A and G7805A) with congenital profound SNHL. This was conserved and had a different RNA structure.

Mit145 harboured C7534T in the D-loop of *tRNAAsp* together with G709A and the rare A8014T mutation in *MT-CO2*. The other novel variant, A7746G, detected in the *MT-CO2* gene, not conserved, was found in a 5-year-old boy also harbouring the T980C variant in *MT*-*RNR1*. A7746G presents a missense mutation with the aminoacidic change Asn\>Ser in the subunit of cytochrome *c* oxidase (complex IV).

Low frequency mutations
-----------------------

We identified several other variants that may be associated with hearing impairment, presenting a low frequency in mtDB and mitomap ([Table IV](#tIV-ijmm-32-04-0785){ref-type="table"}). Among these, we preferably considered the mutations in subjects presenting audiograms compatible to a mitochondrial mutation HL diagnosis, in conserved positions and with a frequency \<0.05%, such as: i) the mutation A\>G in the conserved position 644 (0,04% in mtDB) in *MT-TF*, located in the acceptor stem of *tRNAPhe*. 644A\>G found in a 13-year-old girl with SNHL, harbouring the polymorphisms, G709A, G1888A and C7873T; ii) T721C in *MT-RNR1*. This 36-year-old female had progressive HL which began at age 22; the RNA structure though did not seem to differ from the wild-type one; in fact, we eventually found the same mutation in a 34-year-old male heterozygotic for connexin 26 35delG who was normoacusic; iii) T1119C in *MT*-*RNR1* found in mit110: a 36-year-old patient with progressive post-lingual bilateral SNHL which began at age 33; the RNA showed a different structure; iv) C3342T in the *ND1* gene in two deaf sisters harbouring both the additional mutation T7961C; v) A3808G a mutation in a conserved site found in two sisters with audiograms compatible to mitochondrial deafness; vi) A3847G in a case of a 37-year-old female whose mild sporadic hearing impairment began in her thirties; vii) A7720G in *MT-CO2* in a 3-year-old subject presenting with mild progressive hearing impairment; viii) C7792T in *MT-CO2*, observed in a 42-year-old male with progressive hearing impairment which began in his twenties, presenting with moderate to severe symmetric impairment confirmed by a downward overlapping audiogram; ix) G7830A G7984A together with G709A and G1888A in a 45-year-old female with moderate HL at high frequencies.

Connexin 26 and mtDNA mutations
-------------------------------

We searched for a correlation between mutations in connexin 26 and mtDNA mutations. Eighteen patients only harboured mutations in the *GJB2* gene and 25 of them harboured both the *GJB2* and mtDNA variants (10 of whom were homozygotic for 35delG).

In our subjects, we noticed a higher presence of the G3915A polymorphism, as 5 out of the total 7 probands with this polymorphism in *NDI* were associated with *GJB2* mutations. In two siblings with SNHL and 35delG/35delG in *GJB2,* we identified the missense mutation, T3308C (Met\>Thr), at the highly conserved amino acid position 1 in *MT-ND1*. Among the patients with homozygotic 35delG in *GJB2* we found some rare mutations that may worsen their condition of hearing impairment ([Table V](#tV-ijmm-32-04-0785){ref-type="table"}). The mutations found were A3447G, C3903T, A7717G and G8027A, all in conserved positions in the genes *MT-ND1* and *MT-CO2*. In the literature these were found to be more involved in Leber's hereditary optic neuropathy (LHON) than in HL. Another patient homozygotic for 35delG showed two additional variants: the missense mutation, A3505G, causing the Thr\>Ala substitution in *MT-ND1* and the conserved T1243C mutation in the *MT*-*RNR1* gene.

Discussion
==========

In the present study, we analysed four fragments of mtDNA in 169 subjects with non-syndromic SNHL, both familial and sporadic without a clear aetiology. We compared our data with the DNA of some of their relatives who were normoacusic in order to define whether the mutations were sporadic or genetically transmitted. We also considered the mutations in the *GJB2*, *GJB6* and *SLC26A4* genes which are recognised to be among the most frequent causes of hearing impairment. In total, 43 patients harboured *GJB2* mutations and 18 were affected by *GJB2* mutations only (no mtDNA mutations). We thus decided to exclude this group from our analysis.

The hearing-impaired patients showed a wide range of penetrance, severity and age-at-onset of HL. We searched for mutations in the regions corresponding to the hotspots for deafness: the *MT*-*RNR1* and the *MT-TS1* genes, as the presence of mutations in these two genes in particular, is known to cause both syndromic and non-syndromic forms of hearing impairment; we also focused on the region of *MT*-*TL1* as previous studies report its possible role in non-syndromic disease ([@b29-ijmm-32-04-0785]). In order to establish the potential pathogenicity of the mutations encountered, we analysed the evolutionary conservation comparing our sequences to those of other organisms. Furthermore, considering that the biological functions of 16S rRNA and tRNAs and other structural RNAs are dictated by their three dimensional structures, we analysed the possible RNA secondary structure of the mutated samples and predicted the folding using the Vienna RNA package. Our aim was to detect and correlate the frequency of mtDNA alterations in the cases of deafness showing the typical audiological manifestations of mitochondrial SNHL.

In our cohort of patients, we identified three subjects harbouring the A1555G mutation. This mutation in the *MT*-*RNR1* gene is one of the most common mtDNA variants associated with both non-syndromic progressive SNHL and aminoglycoside-induced SNHL. Sequence analysis of the *MT*-*RNR1* gene in our subjects identified three genetically unrelated individuals harbouring the A1555G mutation who showed the typical mitochondrial HL audiometric features. The incidence of the mutation in hypoacusic subjects was 2%, a little lower than the one recognised by Berrettini *et al*([@b29-ijmm-32-04-0785]) in 2008, but similar to the data presented in the studies by Jacobs *et al*([@b2-ijmm-32-04-0785]) and Lingala *et al*([@b30-ijmm-32-04-0785]). We could not state if the use of aminoglycosides had any effect on these subjects as they could not recall any exposure to antibiotics in the past; however, one of these patients with severe and progressive HL harboured a novel mutation in position 7471 in *tRNA^Ser(UCN)^*, close to position 7472, which has shown to cause both syndromic and non-syndromic deafness ([@b31-ijmm-32-04-0785]), suggesting that this variant somehow functions as a modifier, in synergy with the primary mutation, thus modulating its phenotypic manifestations as observed for other tRNA mutations ([@b32-ijmm-32-04-0785]).

We identified another mutation in the *MT*-*RNR1* gene: seven patients harboured the T961G mutation with a frequency corresponding to data reported in the literature. Its pathogenicity is quite controversial: the mutations at position 961 have been detected in subjects affected by aminoglycoside-induced NSHL. The delT961Cn mutation is more frequent in Caucasian and Asian subjects ([@b16-ijmm-32-04-0785],[@b26-ijmm-32-04-0785],[@b27-ijmm-32-04-0785],[@b33-ijmm-32-04-0785]), as well as the 961C insertion ([@b17-ijmm-32-04-0785],[@b19-ijmm-32-04-0785],[@b27-ijmm-32-04-0785],[@b28-ijmm-32-04-0785]), T961C mutation in Chinese subjects ([@b4-ijmm-32-04-0785]) and T961G mutation in the Caucasian population ([@b17-ijmm-32-04-0785]). In a previous study, Li *et al*([@b28-ijmm-32-04-0785]) found the T961G substitution in 5/164 hearing-impaired paediatric patients of Caucasian descent without a history of exposure to aminoglycoside, while the 226 Caucasian and 324 Chinese control subjects did not harbour this mutation; thus, it was hypothesised that this variant may be associated with SNHL. In contrast to these results indicating a possible pathogenic nature of the mutations around position 961 in NSHL and aminoglycoside-induced HL, Herrnstadt *et al* stated that it could be a typical polymorphism of the H2 haplogroup ([@b34-ijmm-32-04-0785]). The localization of position 961 is at the C-cluster of the region between loop 21 and 22 of *MT*-*RNR1*([@b35-ijmm-32-04-0785]); compared with A1555G this region is not evolutionarily conserved and is in fact highly polymorphic in mammalian interspecies comparisons. Its function is not well defined; in particular, its pathogenic mechanisms of action in the predisposition of carriers to aminoglycoside toxicity remain unclear ([@b17-ijmm-32-04-0785],[@b36-ijmm-32-04-0785]). Elstner *et al* performed a single nucleotide polymorphism (SNP) analysis of the nucleotide 961 in a control group of 320 German samples, finding six T\>C and five T\>G nucleotide changes ([@b37-ijmm-32-04-0785]). Thus, the effects of this mutation have yet not been defined; we confirmed this mutation in our screening; six out of seven patients with T961G showed variable degrees of hearing impairment, suggesting at least a minor role in the HL onset; however, at the same time the mother of two hearing-impaired children harbouring the same mutation did not present with HL. Thus, it can be hypothesised that T961G is either a polymorphism, or a pathogenic mutation with an extremely low penetrance.

One of the subjects in our cohort of patients harboured a novel mutation in position 786 in *MT*-*RNR1*. She did not harbour any other mutations in the genes usually associated with HL or any malformations. This alteration, in our opinion, could be the reason of her HL since its conserved site in the hotspot gene for HL and also as the RNA structure shows a clearly different folding compared with the wild-type one, suggesting a possible malfunctioning of the ribosome. From a clinical point of view, the patient presented with sporadic progressive SNHL with post-lingual onset; her audiometry was compatible with mitochondrial-associated HL and the fact that she was treated with aminoglycosides in the past confirms our hypothesis.

In our patient cohort, some other novel mtDNA variants in genes that are not usually involved in HL or have an association with other pathological conditions were recorded, though their exact role is unclear; thus, they should be investigated, further studied and compared with new cases.

We suggest that some of the rare mutations harboured by patients with audiometric data compatible with a mitochondrial HL are possible candidates for genetic risk factors of NSHL. Among these, we considered T1119C in *MT*-*RNR1*. We suggest that this variant detected in 36-year-old female may be responsible for her mild progressive bilateral SNHL, which began three years earlier. T1119C, already found in four subjects suffering from hearing impairment by Li *et al*([@b4-ijmm-32-04-0785]), located in a conserved site and presenting with a different RNA structure, may be the cause of HL at high frequencies, confirmed by an audiogram. It should be noted that the late onset and gradual worsening of the impairment may reflect the tendency of the mitochondrion to accumulate mutations with aging due to its genomic instability.

Of note, we observed the non-pathogenicity of the T721C mutation in *MT*-*RNR1* that we thought could be responsible for the progressive HL of a 36-year-old female which began at age 22. In fact, we eventually detected the same mutation in a 34-year-old male heterozygotic for connexin 26 35delG who was normoacusic.

In patients harbouring mutations in the most common HL-associated genes (connexin 26), we focused on the mtDNA mutations, in particular T3308C, which results in a change in the initiation codon of NADH dehydrogenase. In a study on mutant cells, Li *et al*([@b38-ijmm-32-04-0785]). demonstrated that T3308C induces a significant decrease in the levels of *MT-ND1,* resulting in a decreased complex I activity; furthermore, the T3308C mutation may also alter the hydrophobicity and antigenicity of the N-terminal peptide of *MT-ND1*([@b39-ijmm-32-04-0785]). These facts suggest that a combination of a mtDNA mutation with other genomic DNA mutations may increase the penetrance of deafness.

In conclusion, our data confirm a frequency of 2% for the A1555G mutation and its role in NSHL; however, the pathogenicity of all the other mtDNA variants encountered should be established: the variability of the frequency in different haplogroups, the occurrence in normal hearing individuals and the correlation with other conditions and mutations should be taken into account; thus, further genetic and functional studies are required in order to define their possible additional correlation with NSHL and/or aminoglycoside-induced HL.

The present study was supported by 'Ospedale Infantile e Pie Fondazioni Burlo Garofolo e dott. Alessandro ed Aglaia de Manussi' Trieste.

![Superimposed audiograms of the three patients with A1555G mutation showing a downsloping trend corresponding to high frequency hearing loss. Hearing measured in decibels Hearing Level (dBHL), frequency in hertz (Hz).](IJMM-32-04-0785-g00){#f1-ijmm-32-04-0785}

![Differences in the predicted *MT*-*RNR1* RNA secondary structure: (A) wild-type, (B) with the T961G mutation, (C) with the novel G786A mutation.](IJMM-32-04-0785-g01){#f2-ijmm-32-04-0785}

###### 

mtDNA alterations detected and conservation.

                                     Hypoacusic (n=168)   \% hypoacusia with no *GJB2* mutation *(*n*=*150)   Cons.   mtDB % on 2704   Mitomap % on GenBank 16411
  ---------------------------------- -------------------- --------------------------------------------------- ------- ---------------- ----------------------------
  Polymorphism                                                                                                                         
   G709A                             18                   12                                                  Yes     16.4             13.79
   T710C                             1                    0.67                                                No      0.89             1.16
   A750G                             166                  100                                                 Yes     99.18            97.64
   G930A                             1                    0.67                                                No      2.25             2.42
   G951A                             3                    2                                                   No      0.29             0.61
   T1189C                            5                    3.33                                                Yes     3.85             4.42
   T1243C                            6                    4                                                   Yes     2.11             1.44
   A1438G                            163                  100                                                 Yes     96.89            94.99
   T1700C                            4                    2.67                                                No      0.18             0.74
   G1719A                            15                   10                                                  No      4.10             4.41
   A1811G                            12                   8                                                   No      7.54             8.49
   G1888A                            9                    6                                                   No      5.32             6.19
   T3336C                            1                    0.67                                                Yes     0.33             0.64
   A3348G                            1                    0.67                                                Yes     1.74             0.80
   T3394C                            2                    1.33                                                Yes     1.44             1.64
   T3396C                            1                    0.67                                                No      0.22             0.83
   A3447G                            1                    0.67                                                Yes     0.44             0.52
   A3480G                            4                    2.67                                                Yes     4.85             5.26
   A3505G                            3                    2                                                   No      2.07             1.25
   G3591A                            2                    1.33                                                No      0.74             0.53
   T3644C                            1                    0.67                                                Yes     0.48             0.67
   G3666A                            1                    0.67                                                No      2.15             2.14
   G3705A                            1                    0.67                                                No      1.15             1.21
   A3720G                            1                    0.67                                                Yes     0.70             0.65
   T3847C                            1                    0.67                                                No      0.26             0.74
   G3915A                            7                    4.67                                                Yes     0.81             1.41
   G7337A                            2                    1.33                                                No      0.55             0.97
   G7521A                            3                    2                                                   No      5.62             5.45
   A7768G                            4                    2.67                                                Yes     2.22             2.16
   G7805A                            1                    0.67                                                No      1.37             0.86
   G7853A                            1                    0.67                                                No      1.66             1.15
   T7961C                            2                    1.33                                                No      0.18             0.72
   G8027A                            1                    0.67                                                No      2.14             3.22
  Possible HL-associated mutations                                                                                                     
   T961G                             6                    4                                                   No      0.18             0.37
  HL-associated mutations                                                                                                              
   A1555G                            3                    2                                                   Yes     0.44             nd
  Novel mutations                                                                                                                      
   C712A                             1                    0.67                                                Yes     nd               nd
   G786A                             1                    0.67                                                Yes     nd               nd
   A3213G                            1                    0.67                                                Yes     nd               nd
   C7534T                            1                    0.67                                                No      nd               nd
   A7746G                            1                    0.67                                                No      nd               nd
  Rare mutations                                                                                                                       
   A644G                             1                    0.67                                                Yes     0.04             0.07
   T721C                             2                    1.33                                                No      0.18             0.24
   T742C                             1                    0.67                                                No      0.07             0.06
   A813G                             1                    0.67                                                No      1.63             0.49
   C867T                             1                    0.67                                                No      0.04             0.03
   A942G                             2                    1.33                                                No      0.11             0.09
   C959T                             1                    0.67                                                No      nd               0.13
   T980C                             2                    1.33                                                No      0.51             0.46
   A1118G                            1                    0.67                                                Yes     0.04             nd
   T1119C                            1                    0.67                                                Yes     0.96             0.45
   T1193C                            1                    0.67                                                Yes     0.29             0.26
   C1405T                            2                    1.33                                                Yes     0.04             nd
   T1406C                            2                    1.33                                                Yes     0.37             0.32
   A1618G                            1                    0.67                                                Yes     0.04             0.03
   A1708T                            1                    0.67                                                Yes     0.04             0.01
   T3308C                            2                    1.33                                                Yes     0.81             0.01
   C3342T                            2                    1.33                                                No      0.04             0.06
   C3388A                            1                    0.67                                                Yes     0.07             0.07
   T3504C                            1                    0.67                                                No      nd               0.12
   A3511G                            1                    0.67                                                No      0.04             0.14
   C3546A                            1                    0.67                                                Yes     0.11             0.05
   T3645C                            1                    0.67                                                No      0.18             0.15
   A3672G                            1                    0.67                                                Yes     0.07             0.14
   A3714G                            2                    1.33                                                Yes     0.15             0.17
   C3741T                            1                    0.67                                                No      0.18             0.20
   C3792T                            1                    0.67                                                No      nd               nd
   A3808G                            2                    1.33                                                Yes     0.04             0.07
   C3903T                            1                    0.67                                                Yes     0.04             nd
   C3936T                            1                    0.67                                                Yes     0.07             0.04
   A7385G                            1                    0.67                                                Yes     0.63             0.40
   T7440G                            1                    0.67                                                No      nd               nd
   C7471T                            1                    0.67                                                No      nd               0.04
   G7642A                            1                    0.67                                                No      0.30             0.25
   T7645C                            2                    1.33                                                No      0.22             0.29
   T7705C                            2                    1.33                                                No      0.18             0.40
   A7717G                            1                    0.67                                                Yes     nd               nd
   A7720G                            1                    0.67                                                Yes     nd               0.01
   C7792T                            1                    0.67                                                Yes     nd               0.04
   G7830A                            1                    0.67                                                No      0.15             0.10
   C7873T                            1                    0.67                                                No      0.15             0.12
   G7984A                            1                    0.67                                                No      0.07             0.07
   A8014T                            1                    0.67                                                No      0.15             0.32

mtDNA, mitochondrial DNA; HL, hearing loss; nd, not determined; Cons., conserved.

###### 

Patients harbouring the hearing loss-associated A1555G mutation.

  Patient   Gender   Age (years)   Homo/heteroplasmy   2d    *GJB2*   *GJB6*   *SLC26A4*   Age of onset (years)   PTA dx   PTA sn   Family history of HL   Other mtDNA mutations   Type of line in [Fig. 1](#f1-ijmm-32-04-0785){ref-type="fig"}
  --------- -------- ------------- ------------------- ----- -------- -------- ----------- ---------------------- -------- -------- ---------------------- ----------------------- ---------------------------------------------------------------
  Mit76     F        47            Homo                Yes   wt       wt       wt          5                      80       81.2     No, sporadic           C7471T; T3504C          Continuous
  Mit114    F        44            Homo                Yes   wt       wt       wt          19                     56.2     75       No, sporadic           No                      Dotted
  Mit140    M        50            Homo                Yes   wt       wt       wt          At birth               80       82.5     nd                     No                      Dashed

2d, differences in the secondary structure; PTA, pure-tone threshold average; dx, right; sn, left; HL, hearing loss; mtDNA, mitochondrial DNA; F, female; M, male; wt, wild-type; nd, not determined.

###### 

Novel mutations.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mutation   Homo/heteroplasmy   Gene     *GJB2*   *GJB6*   *SLC26A4*          Age of onset (years)   PTA dx   PTA sn   Family history of HL   Other mtDNA mutations                    Conserved   Patient   Age (years)   Gender   Notes                  Origin     2d
  ---------- ------------------- -------- -------- -------- ------------------ ---------------------- -------- -------- ---------------------- ---------------------------------------- ----------- --------- ------------- -------- ---------------------- ---------- -----
  C712A      Homo                *RNR1*   wt/wt    wt/wt    nd                 0                      35       40       Uncle?                 A1811G                                   Yes         Mit184    13            M        SNHL\                  Italy\     Yes
                                                                                                                                                                                                                                     Perinatal asphyxia?\   Sardinia   
                                                                                                                                                                                                                                     Normoacusic brother               

  G786A      Hetero              *RNR1*   wt/wt    wt/wt    nd                 Post-lingual           85       72.5     No, sporadic           No                                       Yes         Mit7      39            F        SNHL progressive       Italy      Yes

  A3213G     nd                  *RNR3*   wt/wt    wt/wt    6,7, 8, 10,19 wt   Congenital             95       95       No, sporadic           A3348G; G3591A; A3714G; G7642A; G7805A   Yes         Mit70     4             F        SNHL                   Morocco    No

  A7746G\    Homo                *CO2*    wt/wt    wt/wt    wt/wt              0                      61       59       No, sporadic           T980C                                    No          Mit100    4             M        SNHL otitis CT ok      Italy      Yes
  Asn→Ser                                                                                                                                                                                                                                                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PTA, pure-tone threshold average; dx, right; sn, left; HL, hearing loss; mtDNA, mitochondrial DNA; 2d, differences in the secondary structure; wt, wild-type; nd, not determined; F, female; M, male; SNHL, sensorineural HL; CT, computed tomography.

###### 

Rare mutations.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mutation   Gene       *GJB2*      *GJB6*   *SLC26A4*            Age of onset (years)   PTA dx     PTA sn     Family history of HL   Other mtDNA mutations                    Conserved   Patient       Age (years)   Gender   Notes
  ---------- ---------- ----------- -------- -------------------- ---------------------- ---------- ---------- ---------------------- ---------------------------------------- ----------- ------------- ------------- -------- --------------------------------------------------------
  A644G      *RNR1*     wt/wt       wt/wt    nd                   nd                     40         43.75      No                     G709A; G1888A; C7873T                    Yes         Mit22         13            F        Italy, SNHL, microhematuria, close to 642 (T\>C = HL)

  T721C      *RNR1*     wt/wt       wt/wt    wt/wt                22                     89         81         No, sporadic           No                                       No          Mit109        36            F        Italy, SNHL

  T721C      *RNR1*     35delG/wt   wt/wt    nd                   No                     0          0          No, sporadic           No                                       No          Mit162        34            M        Italy, normoacusic

  A813G      *RNR1*     nd          nd       nd                   nd                     70         70         No, sporadic           No                                       No          Mit58         49            M        Italy, SNHL, MRI ok

  T1119C     *RNR1*     wt/wt       wt/wt    wt/wt                33                     28         25         Maybe mother           G709A; T1243C                            Yes         Mit110        36            F        Italy, progressive SNHL

  C3342T     *ND1*      wt/wt       wt/wt    wt/wt                nd                     61         60         nd                     T7961C                                   No          Mit158--159   45--49        M-F      Italy, SNHL, brothers, medium + high frequencies

  T3504C     *ND1*      wt/wt       wt/wt    wt/wt                5                      80         81.25      No, sporadic           A1555G; C7471T                           No          Mit76         47            F        Italy, SNHL

  A3511G\    *ND1*      wt/wt       wt/wt    wt/wt                0                      54         79         Adopted                G709A; T1193C\                           No          Mit87         8             F        India
  Thr→Ala                                                                                                                             T3394C; G3591A                                                                            

  C3546A     *ND1*      wt/wt       wt/wt    nd                   0                      35         40         Uncle?                 C712A; A1811G                            Yes         Mit184        13            M        Sardinia, SNHL perinatal asphyxia. Normoacusic brother

  T3644C\    *ND1*      wt/wt       wt/wt    nd                   1.2                    122.5      122.5      No, sporadic           T3336C; T3396C                           Yes         Mit61         10            F        Ecuador, SNHL not progressive
  Val→Ala                                                                                                                                                                                                                       

  T3645C     *ND1*      nd          nd       nd                   nd                     Moderate   Moderate   Familial               G1719A; T3645C; G7521A                   No          Mit151        56            F        Italy, SNHL

  A3672G     *ND1*      wt/wt       wt/wt    wt/wt                0                      nd         nd         No, sporadic           A1811G; T7705C                           Yes         Mit167        0             F        Italy, SNHL

  G3705A     *ND1*      wt/wt       wt/wt    wt/wt                2.5                    115        16         No, sporadic           G709A; G1888A; G3705A                    No          Mit127        nd            M        Albania, SNHL

  A3720G     *ND1*      wt/wt       wt/wt    nd                   4                      71         61         No                     A1811G; A3720G                           Yes         Mit129        44            F        Italy, SNHL progressive, otitis

  C3741T     ND1        wt/wt       wt/wt    wt/wt                6 months               nd         nd         No, sporadic           T980C; A1811G                            No          Mit180        3             M        Italy, SNHL\
                                                                                                                                                                                                                                CT/MRI ok\
                                                                                                                                                                                                                                Normoacusic brother

  A3808G     ND1        wt/wt       wt/wt    nd                   nd                     80         82.5       nd                     G1719A                                   Yes         Mit24--25     41--46        F        Italy, SNHL, sisters

  T3847C     ND1        nd          nd       nd                   30                     38.75      38.75      No, sporadic           No                                       Yes         Mit72         37            F        Italy, SNHL

  C3936T     ND1        wt/wt       wt/wt    wt/wt                2.5                    34         75         No, sporadic           No                                       Yes         Mit153        4             M        Italy, SNHL

  A7385G     CO1        wt/wt       wt/wt    nd                   nd                     70         35         No, sporadic           A7768G                                   Yes         Mit57         51            M        Italy, SNHL

  T7440G\    CO1        wt/wt       wt/wt    nd                   7                      nd         nd         No, sporadic           G709A; G1888A; T7440G                    No          Mit143        8             M        Italy SNHL IQ ok. premature
  Ser→Ala                                                                                                                                                                                                                       

  C7471T     S^(UCN)^   wt/wt       wt/wt    wt/wt                nd                     80         81.2       No, sporadic           A1555G; T3504C                           No          Mit76         47            F        Italy SNHL, close to 7,472 known to cause HL

  G7642A     CO2        wt/wt       wt/wt    6, 7, 8, 10, 19 wt   Congenital             95         95         nd                     A3213G; A3348G; G3591A; A3714G; G7805A   No          Mit70         4             F        Morocco, SNHL negative anamnesis

  A7720G     CO2        wt/wt       wt/wt    wt/wt                nd                     19         26         No, sporadic           No                                       Yes         Mit89         3             M        Not Italy, SNHL

  C7792T     CO2        wt/wt       wt/wt    nd                   22                     69         68         nd                     G8020A                                   Yes         Mit142        42            M        Italy SNHL progressive

  G7805A\    CO2        wt/wt       wt/wt    6, 7, 8, 10, 19 wt   Congenital             95         95         nd                     A3213G; A3348G; G3591A; A3714G; G7642A   No          Mit70         4             F        Morocco, SNHL negative anamnesis
  Val→Ile                                                                                                                                                                                                                       

  G7830A\    CO2        wt/wt       wt/wt    wt/wt                nd                     60         60         nd                     G709A; G1888A; G7984A                    Yes         Mit94         46            F        Italy, SNHL
  Arg→His                                                                                                                                                                                                                       

  G7853A     CO2        nd          nd       nd                   nd                     19         26.25      nd                     G709A; G1888A; G7853A                    No          Mit187        5             M        Italy, SNHL

  C7873T     CO2        wt/wt       wt/wt    nd                   nd                     40.00      43.75      No                     A644G; G709A; G1888A; C7873T             No          Mit22         13            F        Italy, SNHL

  G7984A     CO2        wt/wt       wt/wt    wt/wt                nd                     60         60         nd                     G709A; G1888A; G7830A                    No          Mit94         46            F        Italy, SNHL
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PTA, pure-tone threshold average; dx, right; sn, left; HL, hearing loss; mtDNA, mitochondrial DNA; wt, wild-type; nd, not determined; SNHL, sensorineural HL; CT, computed tomography.

###### 

mtDNA and *GJB2* mutations.

  -----------------------------------------------------------------------------------------------------------------
  Sample       mtDNA mutation           Gene              *GJB2*          Notes
  ------------ ------------------------ ----------------- --------------- -----------------------------------------
  Mit1--2      C1405T                   RNR1              35delG/35delG   Severe SNHL, homozygous twins

  Mit46--47    T3308C                   ND1               35delG/35delG   Mild-moderate\
                                                                          SNHL, brothers

  Mit73        A3447G; G8027A           ND1; CO2          35delG/35delG   Profound SNHL, familial

  Mit74        G3915A                   ND1               35delG/35delG   SNHL

  Mit135       T7645C                   CO2               35delG/35delG   Profound SNHL

  Mit154       T1243C; A3505G; C3792T   RNR1; ND1         35delG/35delG   Profound SNHL

  Mit185       A942G; T3394C            RNR1; ND1         35delG/35delG   Moderate SNHL, progressive

  Mitpds7      C3903T; A7717G           ND1; CO2          35delG/35delG   SNHL, congenital, familial

  Mit4         G3915A                   ND1               L90P/M34T       SNHL, congenital

  Mit5         G3915A                   ND1               35delG/L90P     SNHL, congenital

  Mit6         G3915A                   ND1               35delG/L90P     SNHL, congenital

  Mit32        G1719A                   RNR2              35delG/wt       SNHL, progressive, familial

  Mit49        T1189C; A1811G; A3480G   RNR1; RNR2; ND1   R127H/wt        Profound SNHL, familial, onset at age 4

  Mit83--115   G7521A                   TD                L90P/wt         EVA, transmissive\
                                                                          HL, onset at age 3, brothers

  Mit123       G3915A                   ND1               M34T/wt         Moderate SNHL

  Mit133       A1811G; A3480G           RNR2; ND1         35delG/R184P    Profound SNHL, congenital

  Mit139       C959T; G1719A            RNR1; RNR2        wt/35delG       Normoacusic

  Mit145       G709A; C7534T; A8014T    RNR1; TD; CO2     wt/del120E      Normoacusic

  Mit155       A7768G                   CO2               wt/M34T         SNHL, sisters

  Mit156       A7768G                   CO2               35delG/M34T     SNHL, sisters

  Mit162       T721C                    RNR1              35delG/wt       Normoacusic
  -----------------------------------------------------------------------------------------------------------------

mtDNA, mitochondrial DNA; HL, hearing loss; SNHL, sensorineural HL; wt, wild-type; EVA, enlarged vestibular aqueduct.
